Blockage of autophagy pathway enhances Salmonella tumor-targeting

Area of Science:

• Oncology
• Microbiology
• Cell Biology

Background:

• Salmonella typhimurium strains demonstrate tumor-targeting capabilities in preclinical cancer models.
• Tumor-targeting Salmonella typhimurium, such as A1-R and VNP20009, are being investigated for cancer therapy.
• Autophagy is a cellular process involved in cellular defense and survival.

Purpose of the Study:

• To investigate the role of autophagy induced by tumor-targeting Salmonella typhimurium in human cancer cells.
• To determine if inhibiting autophagy enhances the anti-cancer effects of Salmonella typhimurium.
• To evaluate the combined efficacy of autophagy inhibitors and tumor-targeting Salmonella for cancer treatment.

Main Methods:

• Infection of human cancer cells with tumor-targeting Salmonella typhimurium A1-R or VNP20009.
• Knockdown of essential autophagy genes (Atg5, Beclin1) to block the autophagy pathway.
• Treatment with pharmacological autophagy inhibitors (chloroquine, bafilomycin A1).
• Assessment of intracellular bacteria multiplication and cancer cell killing (apoptosis).

Main Results:

• Salmonella typhimurium A1-R and VNP20009 induced autophagy in human cancer cells, acting as a defense response.
• Blocking autophagy via gene knockdown significantly increased intracellular bacterial multiplication.
• Inactivation of autophagy enhanced Salmonella-mediated cancer cell killing by increasing apoptosis.
• Combining autophagy inhibitors (CQ, Baf A1) with Salmonella significantly improved cancer cell killing compared to Salmonella alone.

Conclusions:

• Autophagy acts as a defense mechanism for cancer cells against tumor-targeting Salmonella typhimurium.
• Inhibiting autophagy potentiates the anti-cancer activity of Salmonella typhimurium by promoting bacterial replication and apoptosis.
• The combination of autophagy inhibitors and tumor-targeting Salmonella presents a promising strategy for enhancing cancer therapy.